{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T10:25:07Z","timestamp":1760783107507},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"S1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Bioinformatics"],"published-print":{"date-parts":[[2009,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>The Janus kinase-signal transducer and activator of transcription (JAK\/STAT) pathway is one of the most important targets for myeloproliferative disorder (MPD). Although several efforts toward modeling the pathway using systems biology have been successful, the pathway was not fully investigated in regard to understanding pathological context and to model receptor kinetics and mutation effects.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>We have performed modeling and simulation studies of the JAK\/STAT pathway, including the kinetics of two associated receptors (the erythropoietin receptor and thrombopoietin receptor) with the wild type and a recently reported mutation (JAK2V617F) of the JAK2 protein.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion<\/jats:title>\n            <jats:p>We found that the different kinetics of those two receptors might be important factors that affect the sensitivity of JAK\/STAT signaling to the mutation effect. In addition, our simulation results support clinically observed pathological differences between the two subtypes of MPD with respect to the JAK2V617F mutation.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/1471-2105-10-s1-s53","type":"journal-article","created":{"date-parts":[[2009,1,30]],"date-time":"2009-01-30T20:04:42Z","timestamp":1233345882000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Comparative analysis of the JAK\/STAT signaling through erythropoietin receptor and thrombopoietin receptor using a systems approach"],"prefix":"10.1186","volume":"10","author":[{"given":"Hong-Hee","family":"Won","sequence":"first","affiliation":[]},{"given":"Inho","family":"Park","sequence":"additional","affiliation":[]},{"given":"Eunjung","family":"Lee","sequence":"additional","affiliation":[]},{"given":"Jong-Won","family":"Kim","sequence":"additional","affiliation":[]},{"given":"Doheon","family":"Lee","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2009,1,30]]},"reference":[{"issue":"2","key":"3236_CR1","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1038\/nrc1275","volume":"4","author":"H Yu","year":"2004","unstructured":"Yu H, Jove R: The STATs of cancer \u2013 new molecular targets come of age. Nat Rev Cancer. 2004, 4 (2): 97-105. 10.1038\/nrc1275.","journal-title":"Nat Rev Cancer"},{"issue":"7037","key":"3236_CR2","doi-asserted-by":"publisher","first-page":"1144","DOI":"10.1038\/nature03546","volume":"434","author":"C James","year":"2005","unstructured":"James C, Ugo V, Le Couedic JP, Staerk J, Delhommeau F, Lacout C, Garcon L, Raslova H, Berger R, Bennaceur-Griscelli A: A unique clonal JAK2 mutation leading to constitutive signalling causes polycythaemia vera. Nature. 2005, 434 (7037): 1144-1148. 10.1038\/nature03546.","journal-title":"Nature"},{"issue":"9464","key":"3236_CR3","doi-asserted-by":"publisher","first-page":"1054","DOI":"10.1016\/S0140-6736(05)74230-6","volume":"365","author":"EJ Baxter","year":"2005","unstructured":"Baxter EJ, Scott LM, Campbell PJ, East C, Fourouclas N, Swanton S, Vassiliou GS, Bench AJ, Boyd EM, Curtin N: Acquired mutation of the tyrosine kinase JAK2 in human myeloproliferative disorders. Lancet. 2005, 365 (9464): 1054-1061.","journal-title":"Lancet"},{"issue":"9","key":"3236_CR4","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1038\/nrc2210","volume":"7","author":"RL Levine","year":"2007","unstructured":"Levine RL, Pardanani A, Tefferi A, Gilliland DG: Role of JAK2 in the pathogenesis and therapy of myeloproliferative disorders. Nat Rev Cancer. 2007, 7 (9): 673-683. 10.1038\/nrc2210.","journal-title":"Nat Rev Cancer"},{"issue":"3","key":"3236_CR5","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1182\/blood-2006-12-064287","volume":"110","author":"AM Vannucchi","year":"2007","unstructured":"Vannucchi AM, Antonioli E, Guglielmelli P, Rambaldi A, Barosi G, Marchioli R, Marfisi RM, Finazzi G, Guerini V, Fabris F: Clinical profile of homozygous JAK2 617V>F mutation in patients with polycythemia vera or essential thrombocythemia. Blood. 2007, 110 (3): 840-846. 10.1182\/blood-2006-12-064287.","journal-title":"Blood"},{"issue":"1","key":"3236_CR6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jtbi.2006.11.016","volume":"246","author":"E Shudo","year":"2007","unstructured":"Shudo E, Yang J, Yoshimura A, Iwasa Y: Robustness of the signal transduction system of the mammalian JAK\/STAT pathway and dimerization steps. J Theor Biol. 2007, 246 (1): 1-9. 10.1016\/j.jtbi.2006.11.016.","journal-title":"J Theor Biol"},{"issue":"1\u20133","key":"3236_CR7","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1016\/S0014-5793(02)03842-5","volume":"534","author":"S Yamada","year":"2003","unstructured":"Yamada S, Shiono S, Joo A, Yoshimura A: Control mechanism of JAK\/STAT signal transduction pathway. FEBS Lett. 2003, 534 (1\u20133): 190-196. 10.1016\/S0014-5793(02)03842-5.","journal-title":"FEBS Lett"},{"issue":"1","key":"3236_CR8","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1529\/biophysj.103.029884","volume":"87","author":"JA Papin","year":"2004","unstructured":"Papin JA, Palsson BO: The JAK-STAT signaling network in the human B-cell: an extreme signaling pathway analysis. Biophysical Journal. 2004, 87 (1): 37-46. 10.1529\/biophysj.103.029884.","journal-title":"Biophysical Journal"},{"issue":"5","key":"3236_CR9","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.1016\/j.febslet.2005.01.009","volume":"579","author":"Z Zi","year":"2005","unstructured":"Zi Z, Cho KH, Sung MH, Xia X, Zheng J, Sun Z: In silico identification of the key components and steps in IFN-gamma induced JAK-STAT signaling pathway. FEBS Lett. 2005, 579 (5): 1101-1108. 10.1016\/j.febslet.2005.01.009.","journal-title":"FEBS Lett"},{"issue":"3","key":"3236_CR10","doi-asserted-by":"publisher","first-page":"830","DOI":"10.1016\/j.biosystems.2007.05.005","volume":"90","author":"RP Soebiyanto","year":"2007","unstructured":"Soebiyanto RP, Sreenath SN, Qu CK, Loparo KA, Bunting KD: Complex systems biology approach to understanding coordination of JAK-STAT signaling. Biosystems. 2007, 90 (3): 830-842. 10.1016\/j.biosystems.2007.05.005.","journal-title":"Biosystems"},{"issue":"11","key":"3236_CR11","doi-asserted-by":"publisher","first-page":"4924","DOI":"10.1182\/blood-2006-08-039735","volume":"109","author":"MB Hookham","year":"2007","unstructured":"Hookham MB, Elliott J, Suessmuth Y, Staerk J, Ward AC, Vainchenker W, Percy MJ, McMullin MF, Constantinescu SN, Johnston JA: The myeloproliferative disorder-associated JAK2 V617F mutant escapes negative regulation by suppressor of cytokine signaling 3. Blood. 2007, 109 (11): 4924-4929. 10.1182\/blood-2006-08-039735.","journal-title":"Blood"},{"issue":"2","key":"3236_CR12","doi-asserted-by":"publisher","first-page":"242","DOI":"10.2353\/jmoldx.2007.060125","volume":"9","author":"E Hammond","year":"2007","unstructured":"Hammond E, Shaw K, Carnley B, P'ng S, James I, Herrmann R: Quantitative determination of JAK2 V617F by TaqMan: An absolute measure of averaged copies per cell that may be associated with the different types of myeloproliferative disorders. J Mol Diagn. 2007, 9 (2): 242-248. 10.2353\/jmoldx.2007.060125.","journal-title":"J Mol Diagn"},{"issue":"8","key":"3236_CR13","doi-asserted-by":"publisher","first-page":"3931","DOI":"10.1182\/blood-2007-08-107748","volume":"111","author":"R Tiedt","year":"2008","unstructured":"Tiedt R, Hao-Shen H, Sobas MA, Looser R, Dirnhofer S, Schwaller J, Skoda RC: Ratio of mutant JAK2-V617F to wild-type Jak2 determines the MPD phenotypes in transgenic mice. Blood. 2008, 111 (8): 3931-3940. 10.1182\/blood-2007-08-107748.","journal-title":"Blood"},{"issue":"12","key":"3236_CR14","doi-asserted-by":"publisher","first-page":"2433","DOI":"10.1038\/sj.leu.2404899","volume":"21","author":"T Ishii","year":"2007","unstructured":"Ishii T, Zhao Y, Shi J, Sozer S, Hoffman R, Xu M: T cells from patients with polycythemia vera elaborate growth factors which contribute to endogenous erythroid and megakaryocyte colony formation. Leukemia. 2007, 21 (12): 2433-2441. 10.1038\/sj.leu.2404899.","journal-title":"Leukemia"},{"issue":"8","key":"3236_CR15","doi-asserted-by":"crossref","first-page":"3173","DOI":"10.1182\/blood.V86.8.3173.3173","volume":"86","author":"T Shimamoto","year":"1995","unstructured":"Shimamoto T, Ohyashiki K, Ohyashiki JH, Kawakubo K, Fujimura T, Iwama H, Nakazawa S, Toyama K: The expression pattern of erythrocyte\/megakaryocyte-related transcription factors GATA-1 and the stem cell leukemia gene correlates with hematopoietic differentiation and is associated with outcome of acute myeloid leukemia. Blood. 1995, 86 (8): 3173-3180.","journal-title":"Blood"},{"issue":"2","key":"3236_CR16","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1182\/blood.V93.2.488","volume":"93","author":"DA Persons","year":"1999","unstructured":"Persons DA, Allay JA, Allay ER, Ashmun RA, Orlic D, Jane SM, Cunningham JM, Nienhuis AW: Enforced expression of the GATA-2 transcription factor blocks normal hematopoiesis. Blood. 1999, 93 (2): 488-499.","journal-title":"Blood"},{"issue":"8","key":"3236_CR17","doi-asserted-by":"publisher","first-page":"3265","DOI":"10.1182\/blood-2002-04-1039","volume":"101","author":"AF Gombart","year":"2003","unstructured":"Gombart AF, Kwok SH, Anderson KL, Yamaguchi Y, Torbett BE, Koeffler HP: Regulation of neutrophil and eosinophil secondary granule gene expression by transcription factors C\/EBP epsilon and PU.1. Blood. 2003, 101 (8): 3265-3273. 10.1182\/blood-2002-04-1039.","journal-title":"Blood"},{"issue":"2","key":"3236_CR18","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/S1074-7613(00)00017-0","volume":"13","author":"A Hart","year":"2000","unstructured":"Hart A, Melet F, Grossfeld P, Chien K, Jones C, Tunnacliffe A, Favier R, Bernstein A: Fli-1 is required for murine vascular and megakaryocytic development and is hemizygously deleted in patients with thrombocytopenia. Immunity. 2000, 13 (2): 167-177. 10.1016\/S1074-7613(00)00017-0.","journal-title":"Immunity"},{"issue":"6","key":"3236_CR19","doi-asserted-by":"publisher","first-page":"1327","DOI":"10.1016\/S1097-2765(01)00401-4","volume":"8","author":"LJ Huang","year":"2001","unstructured":"Huang LJ, Constantinescu SN, Lodish HF: The N-terminal domain of Janus kinase 2 is required for Golgi processing and cell surface expression of erythropoietin receptor. Mol Cell. 2001, 8 (6): 1327-1338. 10.1016\/S1097-2765(01)00401-4.","journal-title":"Mol Cell"},{"issue":"52","key":"3236_CR20","doi-asserted-by":"publisher","first-page":"18962","DOI":"10.1073\/pnas.0509714102","volume":"102","author":"X Lu","year":"2005","unstructured":"Lu X, Levine R, Tong W, Wernig G, Pikman Y, Zarnegar S, Gilliland DG, Lodish H: Expression of a homodimeric type I cytokine receptor is required for JAK2V617F-mediated transformation. Proc Natl Acad Sci USA. 2005, 102 (52): 18962-18967. 10.1073\/pnas.0509714102.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"4","key":"3236_CR21","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1093\/bioinformatics\/bti799","volume":"22","author":"H Schmidt","year":"2006","unstructured":"Schmidt H, Jirstrand M: Systems Biology Toolbox for MATLAB: a computational platform for research in systems biology. Bioinformatics (Oxford, England). 2006, 22 (4): 514-515. 10.1093\/bioinformatics\/bti799.","journal-title":"Bioinformatics (Oxford, England)"},{"issue":"2","key":"3236_CR22","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1182\/blood-2004-03-1216","volume":"105","author":"P Walrafen","year":"2005","unstructured":"Walrafen P, Verdier F, Kadri Z, Chretien S, Lacombe C, Mayeux P: Both proteasomes and lysosomes degrade the activated erythropoietin receptor. Blood. 2005, 105 (2): 600-608. 10.1182\/blood-2004-03-1216.","journal-title":"Blood"},{"issue":"1","key":"3236_CR23","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1182\/blood-2002-11-3468","volume":"102","author":"DD Dahlen","year":"2003","unstructured":"Dahlen DD, Broudy VC, Drachman JG: Internalization of the thrombopoietin receptor is regulated by 2 cytoplasmic motifs. Blood. 2003, 102 (1): 102-108. 10.1182\/blood-2002-11-3468.","journal-title":"Blood"},{"issue":"50","key":"3236_CR24","doi-asserted-by":"publisher","first-page":"38930","DOI":"10.1074\/jbc.M607524200","volume":"281","author":"W Tong","year":"2006","unstructured":"Tong W, Sulahian R, Gross AW, Hendon N, Lodish HF, Huang LJ: The membrane-proximal region of the thrombopoietin receptor confers its high surface expression by JAK2-dependent and -independent mechanisms. J Biol Chem. 2006, 281 (50): 38930-38940. 10.1074\/jbc.M607524200.","journal-title":"J Biol Chem"}],"container-title":["BMC Bioinformatics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2105-10-S1-S53.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T10:46:27Z","timestamp":1630493187000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcbioinformatics.biomedcentral.com\/articles\/10.1186\/1471-2105-10-S1-S53"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,1]]},"references-count":24,"journal-issue":{"issue":"S1","published-print":{"date-parts":[[2009,1]]}},"alternative-id":["3236"],"URL":"https:\/\/doi.org\/10.1186\/1471-2105-10-s1-s53","relation":{},"ISSN":["1471-2105"],"issn-type":[{"value":"1471-2105","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,1]]},"assertion":[{"value":"30 January 2009","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"S53"}}